Reversible hyperphagia and obesity in rats with gastric bypass by central MC3/4R blockade

Obesity

Volumn 22, Issue 8, 2014, Pages 1847-1853

  Mumphrey, Michael B ^a   Hao, Zheng ^a   Townsend, R Leigh ^a   Patterson, Laurel M ^a   Morrison, Christopher D ^a   Münzberg, Heike ^a   Stylopoulos, Nicholas ^b   Ye, Jianping ^a   Berthoud, Hans Rudolf ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; INTERMEDIN; MELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENERGY EXPENDITURE; FAT MASS; FOOD INTAKE; HYPERPHAGIA; LIPID DIET; MALE; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; ROUX Y ANASTOMOSIS; SIGNAL TRANSDUCTION; STOMACH BYPASS; WEIGHT REDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; EATING; GASTRIC BYPASS SURGERY; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; EATING; GASTRIC BYPASS; HYPERPHAGIA; MALE; MELANOCORTINS; MELANOCYTE-STIMULATING HORMONES; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELANOCORTIN, TYPE 4; WEIGHT LOSS;

EID: 84904876387     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20773     Document Type: Article

References (36)

1. Cummings DE, Overduin J, Foster-Schubert KE,. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004; 89: 2608-2615.
2. le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007; 246: 780-785.
3. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577-1585.
4. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-1576.
5. Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307: 56-65.
6. Maclean PS, Bergouignan A, Cornier MA, Jackman MR,. Biology's response to dieting: The impetus for weight regain. Am J Physiol Regul Integr Comp Physiol 2011; 301: R581-600.
7. Hajnal A, Kovacs P, Ahmed TA, Meirelles K, Lynch CJ, Cooney RN,. Gastric bypass surgery alters behavioral and neural taste functions for sweet taste in obese rats. Am J Physiol Gastrointest Liver Physiol 2010; 299: G967-G979.
8. le Roux CW, Bueter M, Theis N, et al. Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol 2011; 301: R1057-1066.
9. Schultes B, Ernst B, Wilms B, Thurnheer M, Hallschmid M,. Hedonic hunger is increased in severely obese patients and is reduced after gastric bypass surgery. Am J Clin Nutr 2010; 92: 277-283.
10. Shin AC, Berthoud HR,. Food reward functions as affected by obesity and bariatric surgery. Int J Obes (Lond) 2011; 35 (Suppl 3): S40-44.
11. Shin AC, Zheng H, Pistell PJ, Berthoud HR,. Roux-en-Y gastric bypass surgery changes food reward in rats. Int J Obes (Lond) 2011; 35: 642-651.
12. Scholtz S, Miras AD, Chhina N, et al. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut 2013 Aug 20, doi: 10.1136 [Epub ahead of print].
13. Miras AD, Jackson RN, Jackson SN, et al. Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am J Clin Nutr 2012; 96: 467-473.
14. Ochner CN, Kwok Y, Conceicao E, et al. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg 2011; 253: 502-507.
15. Bueter M, Lowenstein C, Olbers T, et al. Gastric bypass increases energy expenditure in rats. Gastroenterology 2010; 138: 1845-1853.
16. Zheng H, Shin AC, Lenard NR, et al. Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol 2009; 297: R1273-1282.
17. Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud HR,. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010; 151: 1588-1597.
18. Balthasar N, Dalgaard LT, Lee CE, et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005; 123: 493-505.
19. Butler AA, Cone RD,. Knockout models resulting in the development of obesity. Trends Genet 2001; 17: S50-54.
20. Potoczna N, Branson R, Kral JG, et al. Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J Gastrointest Surg 2004; 8: 971-981; discussion 981-972.
21. Aslan IR, Ranadive SA, Ersoy BA, Rogers SJ, Lustig RH, Vaisse C,. Bariatric surgery in a patient with complete MC4R deficiency. Int J Obes (Lond) 2011; 35: 457-461.
22. Zechner JF, Mirshahi UL, Satapati S, et al. Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans. Gastroenterology 2013; 144: 580-590 e587.
23. Aslan IR, Campos GM, Calton MA, Evans DS, Merriman RB, Vaisse C,. Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes Surg 2011; 21: 930-934.
24. Hatoum IJ, Stylopoulos N, Vanhoose AM, et al. Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab 2012.
25. Goergen M, Manzoni D, De Blasi V, et al. Influence of obesity-susceptibility loci (MC4R and INSIG2) on the outcome of weight loss and amelioration of co-morbidity in obese patients treated by a gastric-bypass. Bull Soc Sci Med Grand Duche Luxemb 2011: 7-24.
26. Valette M, Poitou C, Le Beyec J, Bouillot JL, Clement K, Czernichow S,. Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery. PLoS ONE 2012; 7: e48221.
27. Mul JD, Begg DP, Alsters SI, et al. Effect of vertical sleeve gastrectomy in melanocortin receptor 4-deficient rats. Am J Physiol Endocrinol Metab 2012; 303: E103-110.
28. Zheng H, Townsend RL, Shin AC, Patterson LM, Phifer CB, Berthoud HR,. High-fat intake induced by mu-opioid activation of the nucleus accumbens is inhibited by Y1R-blockade and MC3/4R- stimulation. Brain Res 2010; 1350: 131-138.
29. Kunnecke B, Verry P, Benardeau A, von Kienlin M,. Quantitative body composition analysis in awake mice and rats by magnetic resonance relaxometry. Obes Res 2004; 12: 1604-1615.
30. Stefater MA, Perez-Tilve D, Chambers AP, et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology 2010; 138: 2426-2436, 2436.e2421-2423.
31. Nadreau E, Baraboi ED, Samson P, et al. Effects of the biliopancreatic diversion on energy balance in the rat. Int J Obes (Lond) 2006; 30: 419-429.
32. Warne JP, Padilla BE, Horneman HF, et al. Metabolic and neuroendocrine consequences of a duodenal-jejunal bypass in rats on a choice diet. Ann Surg 2009; 249: 269-276.
33. Swarbrick MM, Stanhope KL, Austrheim-Smith IT, et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 2008; 51: 1901-1911.
34. Korner J, Conroy R, Febres G, et al. Randomized double-blind placebo-controlled study of leptin administration after gastric bypass. Obesity (Silver Spring) 2013; 21: 951-956.
35. Meirelles K, Ahmed T, Culnan DM, Lynch CJ, Lang CH, Cooney RN,. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg 2009; 249: 277-285.
36. Still CD, Wood GC, Chu X, et al. High allelic burden of four obesity SNPs is associated with poorer weight loss outcomes following gastric bypass surgery. Obesity (Silver Spring) 2011; 19: 1676-1683.